Optipharm.CO.LTD (153710) — Capital Reinvestment Ratio
Latest as of September 2025:
0.31x
Optipharm.CO.LTD (153710) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩315.25 Million) in capital expenditures (₩97.26 Million). See Optipharm.CO.LTD (153710) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.31x
Capex / Operating Cash Flow
Operating Cash Flow
₩315.25 Million
KRW
Capital Expenditures
₩97.26 Million
KRW
Data as of
Sep 2025
Most recent filing
Optipharm.CO.LTD Capital Reinvestment Ratio (2016–2019)
This chart tracks Optipharm.CO.LTD's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Optipharm.CO.LTD (2016–2019)
Year-by-year Capital Reinvestment Ratio for Optipharm.CO.LTD from 2016 to 2019. For live market cap and broader valuation context, see market cap of Optipharm.CO.LTD.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.40x | ₩447.47 Million | ₩626.46 Million | ▲ +730.3% |
| 2018 | 0.17x | ₩1.20 Billion | ₩202.91 Million | ▼ -93.4% |
| 2017 | 2.57x | ₩260.86 Million | ₩670.33 Million | ▲ +464.7% |
| 2016 | 0.46x | ₩861.36 Million | ₩391.95 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow